Candida species often cause sepsis in very low birthweight (VLBW) infants, leading to formal ophthalmologic evaluation for endophthalmitis. Our experience suggests that endophthalmitis is rare in this setting, and retinal vascular compromise in extreme prematurity may decrease the risk. We studied the prevalence of endophthalmitis in surviving VLBW infants with candidemia.
INTRODUCTION
Candida species cause approximately 12% of late-onset sepsis in very low birth weight (VLBW) infants. 1 Older reports in adults with candidemia showed that from 28 to 40% had concomitant endophthalmitis. 2, 3 In 1981, Baley et al. 4 published a case series of eight neonates with candidal sepsis, four (50%) of whom had endophthalmitis. Initial cultures growing Candida were often considered contaminants. In that era, there was reluctance to initiate antifungal therapy because of concerns with toxicity. Eye examinations have been recommended in all neonates with candidemia because detection of endophthalmitis may influence therapy and outcome. [5] [6] [7] However, several later reports demonstrate a much lower rate of endophthalmitis in premature neonates with candidemia, particularly in those with a birthweight less than 1500 g. 6, 8 In our experience, candidal endophthalmitis is uncommon. Neonates at highest risk for candidemia are also those at highest risk for retinopathy of prematurity (ROP). 9 These infants are already being screened for ROP at 4 to 6 weeks of age, and then every 1 to 3 weeks until the condition resolves. 10 Indirect ophthalmologic examinations can cause considerable stress 11 in critically ill VLBW neonates and have been associated with hypertension, 12 decreased oxygen saturation, and bradycardia. 13 Some infants with systemic candidiasis are too unstable to undergo funduscopic examinations. The apparent infrequent occurrence of candidal endophthalmitis in VLBW neonates led us to wonder what is the prevalence in our NICU of endophthalmitis in VLBW neonates with candidemia.
MATERIALS AND METHODS Study Population
The study population consisted of all VLBW infants who developed candidemia in our NICU between 1994 and 2001. Infants who were too sick to undergo retinal examination were excluded from the analysis. The neonates underwent retinal examination for ROP at regular intervals. Ophthalmology consultations specifically related to the presence of Candida in blood cultures were not routinely requested.
Database Management
The neonatology division maintains a database of clinical information pertaining to all babies admitted to the NICU. This database contains demographic, morbidity, and outcomes data.
The division also maintains a database of all ROP screening retinal examinations. In addition, the microbiology laboratory maintains a clinical microbiology database. All three databases are maintained prospectively. Study infants who developed candidemia were identified through the microbiology laboratory database and then matched to the clinical information contained in the NICU and ROP databases. As needed, medical records were reviewed to confirm the accuracy of the database information.
Data pertaining to the each episode of candidemia were extracted from the databases. Estimated gestational age at birth, birthweight, route of delivery, clinical presentation of candidemia, species of Candida isolated, age at the time of candidemia, type and duration of antifungal therapy, and outcomes were ascertained. The primary data points were the timing of ophthalmologic evaluation and the presence or absence of candidal endophthalmitis. Data from the neonatal database, the ROP database, and the microbiology database were entered into a study database for retrospective analysis. The study was granted exemption by the Institutional Review Board of Eastern Virginia Medical School because it was a research study of existing data recorded in such a way that the subjects cannot be identified.
Definitions
Candidemia was defined as the growth of any species of Candida from at least one blood culture. Candidal endophthalmitis was defined clinically as the presence of white fluffy retinal lesions on ophthalmological examination.
Clinical Data
Initial ROP screening was performed before 6 weeks of age by one of four board-certified ophthalmologists and staged accordingly. Follow-up ophthalmologic examinations were performed at 1-to 3-week intervals until vascularization proceeded to zone III. The attending neonatologist determined GA when the infant was admitted to the NICU. Blood cultures were collected and processed according to standard microbiologic techniques.
RESULTS
We identified 147 cases of culture-proven candidemia in VLBW infants in the NICU in the 8 years between 1994 and 2001. In all, 24 patients were excluded because they were too unstable to undergo retinal examination; 21 of those died from candidemia and three others died from other causes after the candidemia had resolved. Thus, the study group consisted of 123 VLBW infants with candidemia who were stable enough to have retinal examinations.
The median birth weight was 735 g (range, 426 to 1460 g) and the median gestational age was 25 weeks (range, 23 to 32 weeks). Of the study group infants, 100 (81%) had birth weight <1000 g. In all, 81 (66%) were African-American, and 71 (58%) were male. The median age at the time the diagnosis of candidemia was 27 days (range, 4 to 163 days). The median duration of candidemia was 4 days (range, 1 to 38 days). Of the blood isolates, 74 (60%) were Candida parapsilosis and 41 (33%) were Candida albicans. All babies were treated with amphotericin B at a dose of 1 mg/kg/day. They were treated for a median of 21 days (range, 10 to 51 days).
The study infants had an indirect ophthalmologic examination a median of 12 days (range, 0 to 39 days) after the first blood culture turned positive for Candida species. They underwent a median of 6 (range, 1 to 17) funduscopic examinations after the onset of candidemia. Threshold retinopathy of prematurity developed in 24 (20%) of cases.
Of the 123 neonates with candidemia, only one developed endophthalmitis, for a prevalence of 0.8% (95% confidence interval: 0 to 4%). There were no cases of macular or perimacular scars in the study group on follow-up retinal examinations. The infant who developed endophthalmitis had a birth weight of 500 g and a gestational age of 27 weeks. C. albicans was recovered from only one blood culture at 32 days of age. There were bilateral knee effusions that required incision and drainage on two occasions. The infant was treated with a total of 4 weeks of amphotericin B therapy because of presumed candidal arthritis. A ''snowball'' lesion was seen in the right eye near the optic disc on retinal examination performed 6 days after the positive blood culture. There was no associated vitreal reaction. Within 1 week the lesion was noted to be regressing, and by 2 weeks it had disappeared entirely. The infant underwent a total of seven retinal examinations and his worst stage of ROP was stage 1. The results of retinal examination altered neither the timing nor the duration of his antifungal therapy.
SIGNIFICANCE
This study, the largest survey for ophthalmologic end-organ damage in VLBW neonates with candidemia, demonstrates that the prevalence of endophthalmitis in VLBW infants who survive candidemia is considerably lower than estimates that were extrapolated from adult studies and neonatal series published in the early 1980s. In our institution over an 8-year period, we were able to identify only one case out of 123 patients. Thus, the prevalence of endophthalmitis in this patient population was less than 1%, with 95% confidence intervals of from 0 to 4%. These results are compatible with more recent estimations of the risk of endophthalmitis. In 2000, Chapman and Faix found no cases in 84 neonates with systemic candidiasis. 8 In 2001, Makhoul et al. 14 reported no cases of endophthalmitis among 49 babies with acquired fungal sepsis. Also in 2001, Noyola et al. 6 found only four cases (6%) of endophthalmitis in a series of 67 infants with candidemia. Furthermore, only one of the four with endophthalmitis had a birth weight less than 1500 g. In fact, in their study population, candidal endophthalmitis occurred significantly more often in neonates with birth weight greater than 1500 g. We believe it is likely that the rate of this complication of systemic fungal infection has changed, and that the decrease is probably a result of more timely and aggressive treatment of candidemia in these patients. It is also possible that the rate of endophthalmitis has always been low, but an improvement in reporting bias makes it appear as though the risk has changed.
This study has several limitations. Although it is a retrospective study, it should be noted that all the databases used for the study are prospectively maintained. This practice should minimize bias. Babies who were too sick to undergo retinal examination were excluded from the study. A higher prevalence of endophthalmitis might have been found if all patients had been examined. Even if only two or three of these babies had endophthalmitis, the rate of this complication would be compatible with previously published studies. Clinically, however, this is of marginal relevance given the fact that all 24 of the babies expired, 21 of them from overwhelming candidal sepsis, and the outcome of interest is endophthalmitis in surviving infants. Furthermore, it is noteworthy that even in NICUs in which retinal examination is routinely attempted to screen for endophthalmitis, 13% 8 to 22% 6 are not examined due to technical difficulties and intolerance of examination.
As we did not routinely order ophthalmologic examinations at the time candidemia was first diagnosed, many of the babies did not get their eyes examined until days to several weeks after candidemia was detected. Cases of endophthalmitis might have resolved before the infants had retinal examinations and a higher prevalence of endophthalmitis might have been found if the infants had been examined earlier. We believe that any such cases, if they existed, are not clinically relevant because of their short-lived nature and because there were no cases of macular or perimacular scars in the study group on follow-up retinal examinations. The fact that our patients with candidemia were treated for a median of 21 days may also have improved long-term outcomes.
Compared with previous case series in which C. albicans was the predominant organism, 60% of the isolates in our study group were C. parapsilosis, generally considered to be less virulent than C. albicans. 15 However, the prevalence of end-organ damage with various species of Candida has not been well defined. Additionally, recent trends suggest that nonalbicans species are becoming more common. 16, 17 The fact that all the neonates in this study were at a single institution may affect the generalizability of the data, as it is possible that there may be regional differences in rates of fungal endophthalmitis, based either on differential virulence of isolates or on regional differences in approach to the treatment of candidemia. Obviously, a multicenter study would be optimal.
Another factor that may have contributed to our very low prevalence of endophthalmitis was that 100 (81%) of study group infants with candidemia were extremely low birth weight (ELBW) with birth weights <1000 g. Neither Chapman and Faix 8 nor Makhoul et al. 14 reported the number or percentage of ELBW infants with candidemia. Noyola et al. 6 reported that 66 (or 72%) of cases of candidemia occurred in ELBW infants, but did not specify how many did or did not have retinal examinations, other than reporting that 22% of the entire study group did not have retinal examinations. Noyola et al. 6 speculated that ELBW infants might have lower risk for candidal endophthalmitis because retinal vascular compromise, which places them at increased risk of severe ROP, may have a protective effect against candidal endophthalmitis by reducing the chance of hematogenous spread of Candida to the premature retina. Noyola et al. 6 further speculated that characteristic retinal lesions might not be evident on retinal examination in ELBW infants, because of the severely blunted inflammatory response in these immunologically very immature infants.
Pappas et al. 18 noted that recent large prospective therapy studies, which included careful ophthalmologic examinations, indicate that candidal endophthalmitis is now rare in adults, in that there were no cases in 441 successfully treated subjects. [19] [20] [21] Nevertheless, the 2004 Infectious Disease Society of America (IDSA) Guidelines 18 for treatment of candidiasis recommend that all patients with candidemia undergo at least one ophthalmologic examination to exclude the possibility of candidal endophthalmitis. However, considering the fact that endophthalmitis rarely develops following an otherwise successful course of therapy, the 2004 IDSA Guidelines recommend that the ophthalmologic examination be performed preferably when the candidemia appears controlled and new spread to the eye is thus unlikely. 18 In summary, although Candida species are a frequent cause of sepsis in VLBW infants, our data suggest that endophthalmitis in this setting is rare, which also corresponds with recent experience in adults with candidiasis. In our experience, the results of ophthalmologic evaluation in VLBW infants altered neither the course of antifungal therapy nor the outcome of candidemia. VLBW infants are at risk for ROP and they are already receiving scheduled retinal examinations. At this time perhaps the most prudent approach would be to make sure that each infant with candidemia gets one retinal examination prior to the cessation of antifungal therapy. This examination should not be performed too early, as the 2004 IDSA guidelines advise against retinal examination during the acute and unstable phase of candidemia. 18 Perhaps the consulting ophthalmologist could perform both the ROP examination and the examination for complications of fungemia simultaneously.
In contrast to ELBW infants, Noyola et al. 6 reported that candidal endophthalmitis occurred significantly more often in neonates with birth weight greater than 1500 g. These infants do not routinely get ophthalmologic examinations to screen for ROP. It is imperative that neonates with candidemia whose birth weight is greater than 1500 g undergo at least one retinal examination, when the candidemia appears controlled, in order to exclude the possibility of candidal endophthalmitis and to monitor for macular or perimacular scars.
